The regulatory effect of Liuwei Dihuang Pills on cytokines in mice with experimental autoimmune encephalomyelitis

American Journal of Chinese Medicine

Volumn 40, Issue 2, 2012, Pages 295-308

  Liu, Yan ^a,c   Zhao, Hui ^a   Zhang, Jie ^a   Zhang, Ping ^b   Li, Ming ^a   Qi, Fang ^a   Wang, Yizhou ^a   Kou, Shuang ^a   Zheng, Qi ^a   Wang, Lei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b WANGJING HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Experimental Autoimmune Encephalomyelitis; Liuwei Dihuang Pills; Multiple Sclerosis; TGF ; TNF

Indexed keywords

CHINESE DRUG; CYCLIC AMP; EOSIN; FREUND ADJUVANT; HEMATOXYLIN; LIUWEI DIHUANG; PERTUSSIS TOXIN; PREDNISONE ACETATE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MOUSE; NERVE FIBER; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL;

ANIMALS; CYTOKINES; DRUGS, CHINESE HERBAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; SPINAL CORD; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863378085     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500231     Document Type: Article

References (42)

1. Aranami, T. and T. Yamamura. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 57: 115-120, 2008. (Pubitemid 351897665)
2. Brown, M.A., M.B. Tanzola and M. Robbie-Ryan. Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38: 1373-1378, 2002. (Pubitemid 35253780)
3. Cheng, X.R., W.X. Zhou and Y.X. Zhang. The effects of Liuwei Dihuang decoction on the gene expression in the hippocampus of senescence-accelerated mouse. Fitoterapia 78: 175-181, 2007.
4. Fan, Y.P. Treatment of disseminated sclerosis combining disease and syndrome with traditional Chinese medicine. China J. Tradit. Chin. Med. Pharm. 22: 289-292, 2007.
5. Fan, X.F. and J.X. He. An example of treatment of multiple sclerosis with Liuwei Dihuang Pills. J. Tradit. Chin. Med. 40: 314, 1999.
6. Folcik, V.A., T. Smith, S. O'Bryant, J.A. Kawczak, B. Zhu, H. Sakurai, A. Kajiwara, J.M. Staddon, A. Glabinski, A.L. Chernosky, M. Tani, J.M. Johnson, V.K. Tuohy, L.L. Rubin and R.M. Ransohoff. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis, an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors. J. Neuroimmunol. 97: 119-128, 1999. (Pubitemid 29301421)
7. Furlan, R., C. Cuomo and G. Martino. Animal models of multiple sclerosis. Methods Mol. Biol. 549: 157-173, 2009.
8. Furuzawa-Carballeda, J., M.I. Vargas-Rojas and A.R. Cabral. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6: 169-175, 2007. (Pubitemid 46187336)
9. Imitola, J., T. Chitnis and S.J. Khoury. Cytokines in multiple sclerosis, from bench to bedside. Pharmacol. Ther. 106: 163-177, 2005. (Pubitemid 40603863)
10. Juedes, A.E., P. Hjelmström, C.M. Bergman, A.L. Neild and N.H. Ruddle. Kinetics and cellular origin of cytokines in the central nervous system, insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 164: 419-426, 2000. (Pubitemid 30013017)
11. Kenealy, S.J., M.A. Pericak-Vance and J.L. Haines. The genetic epidemiology of multiple sclerosis. J. Neuroimmunol. 143: 7-12, 2003. (Pubitemid 37336469)
12. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo and Y. Iwakura. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573, 2006. (Pubitemid 43939170)
13. Kuklina E.M. and S.V. Shirshev. Role of cAMP-dependent signal transduction in the control of-Rftxt lymphocyte activation. Biochem. Moscow 65: 629-639, 2000.
14. Li, Q., Q. Zhan, J. Ju and W.T. Zhan. Professor Zhan Wentao's experience on treatment of multiple sclerosis based on syndrome differentiation. J. Beijing Univ. Tradit. Chin. Med. 10: 18-20, 2003.
15. Liao, H.F., M.C. Lu, H.C. Chang, C.C. Wei, C.H. Kao, Z.H. Chen, C.C. Huang and C. Li. Effects of herbal medicinal formulas on suppressing viral replication and modulating immune responses. Am. J. Chin. Med. 38: 173-190, 2010.
16. Liu, H.R., X.Y. Tang, D.Z. Dai and Y. Dai. Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats. J. Ethnopharmacol. 118: 466-472, 2008a.
17. Liu, Y. and L. Wang. The progression of the modern pharmacology research on formulae of Liuwei Dihuang and Jingui Shenqi. China J. Tradit. Chin. Med. Pharm. 23: 996-998, 2008b.
18. Liu, Y., L. Wang, H. Zhao, Y. Mu, M.Y. Li, M. Li, F. Qi and Y.Z. Wang. The effects of Liuweidihuang pills and Jinguishenqi pills on lymphocyte subgroups and natural killer cells in mice with experimental autoimmune encephalomyelitis. Chin. J. Exp. Tradit. Med. Form. 15: 42-47, 2009.
19. Liu, Y., P. Zhang, M. Li, F. Qi, L.L. Yin, Y.Z. Wang, S. Kou, Q. Zheng, H. Zhao and L. Wang. Effect of Bushen Formulae on T helper cell 1, 17 and regulatory T cell in experimental autoimmune encephalomyelitis mice. Chin. J. Exp. Tradit. Med. Form. 17: 116-120, 2011.
20. Liu, Y.M., X.J. Liu, S.S. Bai, L.L. Mu, Q.F. Kong, B. Sun, D.D. Wang, J.H. Wang, S. Shu, G.Y. Wang and H.L. Li. The effect of electroacupuncture on T cell responses in rats with experimental autoimmune encephalitis. J. Neuroimmunol. 220: 25-33, 2010.
21. Ma, R.H., B.Y. Yang, and C.Y. Wu. A selective phosphodiesterase 4 (PDE4) inhibitor Zl-n-91 suppresses IL-17 production by human memory Th17 cells. Int. Immunopharmacol. 8: 1408-1417, 2008.
22. Mangan, P.R., L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb and C.T. Weaver. Transforming growth factor-beta induces development of the TH17 lineage. Nature 441: 231-234, 2006.
23. Marrie, R.A. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 3: 709-718, 2004. (Pubitemid 39535256)
24. Molina-Holgado, E., A. Areválo-Martín, J.M. Vela and C. Guaza. Theiler's virus encephalomyelitis infection as a model for multiple sclerosis, cytokines and pathogenic mechanisms. Rev. Neurol. 35: 973-978, 2002. (Pubitemid 35448327)
25. Park, H., Z.X. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141, 2005. (Pubitemid 41541791)
26. Penkowa, M. and J. Hidalgo. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF- and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE). Exp. Neurol. 170: 1-14, 2001.
27. Salinthone, S., R.V. Schillace, G.H. Marracci, D.N. Bourdette and D.W. Carr. Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells. J. Neuroimmunol. 199: 46-55, 2008.
28. Sloane, E., A. Ledeboer, W. Seibert, B. Coats, M. Van Strien, S.F. Maier, K.W. Johnson, R. Chavez, L.R. Watkins, L. Leinwand, E.D. Milligan and A.M. Van Dam. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis, MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav. Immun. 23: 92-100, 2009.
29. Stüve, O. Knowns and unknowns in the future of multiple sclerosis treatment. J. Neurol. Sci. 287: S30-S36, 2009.
30. Sun, D., T.A. Newman, V.H. Perry and R.O. Weller. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord, implications for multiple sclerosis. Neuropathol. Appl. Neurobiol. 30: 374-384, 2004. (Pubitemid 39120299)
31. Tzartos, J.S., M.A. Friese, M.J. Craner, J. Palace, J. Newcombe, M.M. Esiri and L. Fugger. Interleukin- 17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155, 2008. (Pubitemid 351186376)
32. Verrecchia, F. and A. Mauviel. TGF-beta and TNF-alpha, antagonistic cytokines controlling type-Rfis1 collagen gene expression. Cell Signal. 16: 873-880, 2004. (Pubitemid 38638777)
33. Wahl, S.M., J.M. Orenstein and W.J. Chen. TGF-β influences the life and death decisions of-Rftxt lymphocytes. Cytokine Growth Factor Rev. 11: 71-79, 2000. (Pubitemid 30169727)
34. Weaver, C.T., R.D. Hatton, P.R. Mangan and L.E. Harrington. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852, 2007. (Pubitemid 46697925)
35. Wu, C.R., L.W. Lin, W.H. Wang and M.T. Hsieh. The ameliorating effects of LiuWei Dihuang Wang on cycloheximide-induced impairment of passive avoidance performance in rats. J. Ethnopharmacol. 113: 79-84, 2007.
36. Xie, L., X.K. Li, N. Funeshima-Fuji, H. Kimura, Y. Matsumoto, Y. Isaka and S. Takahara. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int. Immunopharmacol. 9: 575-581, 2009.
37. Xu, S.Y., R.L. Bian and X. Chen (eds.), The Methodology of Pharmacological Experiment. People'S Medicinal Publishing House, Beijing, 2003, pp. 202-204.
38. Yang, L., D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, M. Oukka, V.K. Kuchroo and D.A. Hafler. IL-21 and TGF-beta are required for differentiation of human T (H)17 cells. Nature 454: 350-352, 2008.
39. Zhang, B.P., Y. Tang and Z.L. Chen. Treating multiple sclerosis from the liver and kidney. J. Zhejiang Tradit. Chin. Med. 41: 16-17, 2006a.
40. Zhang, R., A. Tian, H. Zhang, Z. Zhou, H. Yu and L. Chen. Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance. J. Mol. Neurosci. 44: 31-40, 2011.
41. Zhang, X.M., J. Reddy, H. Ochi, D. Frenkel, V.K. Kuchroo and H.L. Weiner. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4p LAPp and CD4p CD25p T cells. Int. Immunol. 18: 495-503, 2006b.
42. Zhang, Y.X. and Y.M. Zhao (eds.). Modern Pharmacology and Chemical Research on Liuei Dihuang Decoction. Science Press, Beijing, 2006, pp. 21-161.